Indegene board approves record date for final dividend

Indegene Ltd. | Business Support | Miscellaneous | BSE: 544172 | NSE: INDGN

16 Jul 2026 Evaluate

Indegene has informed that the Board of Directors of Indegene, at its meeting held on Wednesday, July 15, 2026, has, approved- The 28th Annual General Meeting (“AGM”) of the Company will be held on Thursday, 13 August, 2026 at 16:30 hours (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (OAVM), in compliance with applicable circulars issued by the Ministry of Corporate Affairs (‘MCA circulars’), and as per the provisions of the Companies Act, 2013 and Rules framed thereunder (the Act) and the SEBI Listing Regulations, to transact the business as set out in the Notice convening the AGM; As informed earlier, the Board of Directors of the Company, at its meeting held on 29 April, 2026, had recommended a final dividend of ?2.25 per equity share of face value ?2 each for the financial year ended 31 March 2026, subject to approval of the shareholders at the ensuing AGM. Pursuant to Regulation 42 of the SEBI Listing Regulations, the Company has fixed Friday, 31 July, 2026, as the ‘Record Date’ for determining the eligibility of Members for receiving the aforesaid final dividend, for the financial year ended 31 March 2026; Consequent to the changes in the composition of the Board of Directors, the Audit Committee, Risk Management Committee and Investment Committee have been reconstituted as follows: Appointment of Dr. Georgia Nikolakopoulou Papathomas as a Member of the Risk Management Committee and re-designation of Dr. Sanjay Suresh Parikh as the Chairperson of the Risk Management Committee ii. Appointment of Ms. Jill Mary de Simone as a Member of the Investment Committee; and iii. Cessation of Dr. Sanjay Suresh Parikh as a Member of the Audit Committee. The composition of the reconstituted committees is provided in Annexure – I. The meeting of the Board of Directors commenced at 06:00 PM (IST) and concluded at 06:21 PM (IST). The above information will be made available on the website of the Company: https://www.indegene.com/.

The above information is a part of company’s filings submitted to BSE.

Indegene Share Price

567.05 4.80 (0.85%)

18-Aug-2026 16:59 View Price Chart

Peers

Company Name	CMP
Indegene	567.05
Syngene Internatl.	403.65
JITF Infralogistics	306.95
CMS Info Systems	249.60
Sagility	42.15
View more..

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

Address : The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.